Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...
We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to ...
Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...
10h
24/7 Wall St. on MSNCathie Wood Sours on Tesla and Moderna, but Likes These Stocks InsteadStar portfolio manager Cathie Wood’s Ark Investment Management filed its 13F holdings report for the fourth quarter on Feb. 4 ...
1d
Zacks.com on MSNModerna (MRNA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 ReleaseModerna (MRNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...
A complainant shared four third-party posts on X (formerly Twitter) and two online articles with the PMCPA to make the case ...
We recently published a list of These 10 Stocks Were Wednesday’s Worst Performers. In this article, we are going to take a ...
A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...
Delving into the details, we found 51% of traders were bullish, while 25% showed bearish tendencies. Out of all the trades we ...
Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results